- Home
- DOMH vs BRTX Comparison
DOMH vs BRTX Comparison
Compare DOMH & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- BRTX
- Stock Information
- Founded
- DOMH 1967
- BRTX 1997
- Country
- DOMH United States
- BRTX United States
- Employees
- DOMH N/A
- BRTX N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- BRTX Managed Health Care
- Sector
- DOMH Health Care
- BRTX Health Care
- Exchange
- DOMH Nasdaq
- BRTX Nasdaq
- Market Cap
- DOMH 83.3M
- BRTX 12.6M
- IPO Year
- DOMH N/A
- BRTX N/A
- Fundamental
- Price
- DOMH $5.44
- BRTX $1.67
- Analyst Decision
- DOMH
- BRTX Strong Buy
- Analyst Count
- DOMH 0
- BRTX 1
- Target Price
- DOMH N/A
- BRTX $18.00
- AVG Volume (30 Days)
- DOMH 312.8K
- BRTX 256.1K
- Earning Date
- DOMH 08-07-2025
- BRTX 08-12-2025
- Dividend Yield
- DOMH 5.84%
- BRTX N/A
- EPS Growth
- DOMH N/A
- BRTX N/A
- EPS
- DOMH N/A
- BRTX N/A
- Revenue
- DOMH $24,891,000.00
- BRTX $391,000.00
- Revenue This Year
- DOMH N/A
- BRTX $391.52
- Revenue Next Year
- DOMH N/A
- BRTX $3.50
- P/E Ratio
- DOMH N/A
- BRTX N/A
- Revenue Growth
- DOMH 630.80
- BRTX 161.54
- 52 Week Low
- DOMH $0.83
- BRTX $1.21
- 52 Week High
- DOMH $13.58
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- DOMH 51.73
- BRTX 46.78
- Support Level
- DOMH $5.47
- BRTX $1.57
- Resistance Level
- DOMH $6.08
- BRTX $1.72
- Average True Range (ATR)
- DOMH 0.55
- BRTX 0.13
- MACD
- DOMH 0.02
- BRTX -0.01
- Stochastic Oscillator
- DOMH 35.76
- BRTX 20.65
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.